Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 8:00 PM ET

Life Sciences Tools and Services

Company Overview of KAI Research, Inc.

Company Overview

KAI Research, Inc. operates as a clinical research organization (CRO). It focuses on providing various services, including clinical studies support, clinical data management systems, pharmacovigilance and clinical safety, medical communications, data warehousing, statistical analysis and SAS programming, quality assurance, and registries. The company provides CRO services for phase I-IV clinical trials and epidemiological studies in various therapeutic areas, including CNS, dermatology, endocrinology, infectious diseases, pain, psychiatric disorders, rheumatology, substance abuse, and vaccines. It also offers a suite of clinical trial systems, including an electronic data capture system; an ...

11300 Rockville Pike

Suite 500

Rockville, MD 20852-4801

United States

Founded in 1986





Key Executives for KAI Research, Inc.

Founder and Senior Clinical Research Scientist
Founder and Senior Clinical Research Scientist
Deputy Director and Senior Clinical Research Manager
Compensation as of Fiscal Year 2015.

KAI Research, Inc. Key Developments

KAI Research, Inc. Wins $2,865,098 Federal Contract

KAI Research Inc., Rockville, Maryland, won a federal contract valued at up to $2,865,098 from the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention, Atlanta, for research and development of anonymous pre and post influenza vaccine sera panels.

Centers for Disease Control and Prevention Awards Contract to KAI Research, Inc

KAI Research, Inc. announced that the Centers for Disease Control and Prevention (CDC) awarded it a contract to evaluate samples of pediatric, adult, and elderly individuals' serum levels after flu vaccination to determine whether antibodies induced by the current vaccine effectively inhibit circulating influenza viruses.

Similar Private Companies By Industry

Company Name Region
Extera Partners, LLC United States
Dow Pharmaceutical Sciences, Inc. United States
RadCore Lab, LLC United States
Zymergen, Inc. United States
Hridaya, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KAI Research, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at